Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|July 17, 2008
[Strategy of molecular design of drugs: the unification of macro-properties and micro-structures of a molecule]Zong-Ru GuoYao Xue Xue Bao = Acta Pharmaceutica Sinica|May 20, 2009
[Strategy of molecular drug design: dual-target drug design]Zong-ru GuoYao Xue Xue Bao = Acta Pharmaceutica Sinica|October 14, 2010
[Synthesis and activity of some new histone deacetylases inhibitors]Yong-Hao Cheng, Yan-Shen Guo, Hai-Zhu Han, et al.Yao Xue Xue Bao = Acta Pharmaceutica Sinica|October 19, 2013
[Challenges and strategies of drug innovation]Zong-Ru Guo, Hong-Yu ZhaoYao Xue Xue Bao = Acta Pharmaceutica Sinica|February 13, 2003
[Three dimensional quantitative structure-activity relationship of a series of benzocylohepatpyridine farnesyltransferase inhibitors]Sheng-biao Wan, Xiang Yi, Zong-ru GuoActa Pharmacologica Sinica|March 29, 2002
Molecular simulation of interaction between estrogen receptor and selective estrogen receptor modulatorsZong-Ru Guo, Xiang Yi, Zhi-Bin XuYao Xue Xue Bao = Acta Pharmaceutica Sinica|August 14, 2003
7-imidazolylalkanamido-1-carboxylalkylbenzo-diazepine, a novel series of farnesyltransferase inhibitorsSheng-biao Wan, Feng-ming Chu, Zong-ru GuoActa Pharmacologica Sinica|July 31, 2002
Inhibitory effect of 3,4-diaryl-3-pyrrolin-2-one derivatives on cyclooxygenase 1 and 2 in murine peritoneal macrophagesFang Shen, Ai-Ping Bai, Zong-Ru Guo, et al.Acta Pharmacologica Sinica|April 22, 2006
Synthesis and anti-diabetic activity of (RS)-2-ethoxy-3-{4-[2-(4-trifluoro-methanesulfonyloxy-phenyl)-ethoxy]-phenyl}-propionic acidZhe-Feng Cai, Quan Liu, Ping-Ping Li, et al.Pageof 4